SEC Form 4 · accession 0001931406-26-000007
MYRIAD GENETICS INC · MYGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vishal Sikri
Officer — EVP, Commercial
Period of report
Sep 16, 2026
Accepted (ET)
Sep 17, 2026 · 4:34 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000899923
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 16, 2026 | A | 257,731 | $0.00 | A | 351,224 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Consists of time-based restricted stock units granted pursuant to the Issuer's 2026 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date.